Sleep disturbances and circadian rhythm dysfunction have been widely demonstrated in patients with bipolar disorder (BD). Irregularity of the sleep-wake rhythm, eveningness chronotype, abnormality of melatonin secretion, vulnerability of clock genes, and the irregularity of social time cues have also been well-documented in BD. Circadian rhythm dysfunction is prominent in BD compared with that in major depressive disorders, implying that circadian rhythm dysfunction is a trait marker of BD. In the clinical course of BD, the circadian rhythm dysfunctions may act as predictors for the first onset of BD and the relapse of mood episodes. Treatments focusing on sleep disturbances and circadian rhythm dysfunction in combination with pharmacological, psychosocial, and chronobiological treatments are believed to be useful for relapse prevention. Further studies are therefore warranted to clarify the relation between circadian rhythm dysfunction and the pathophysiology of BD to develop treatment strategies for achieving recovery in BD patients.
B
IPOLAR DISORDER (BD) IS characterized by repetitive relapse of mood episodes during the clinical course of the disorder. 1, 2 Sleep problems are commonly noted during the depressive episodes, manic episodes, and even euthymic episodes in patients with BD, as per the DSM-5. 3 A reduced need for sleep is frequently observed in manic episodes, whereas insomnia and hypersomnia are commonly noted in depressive episodes. 4 A recent study suggested that sleep problems are also frequent in the euthymic period 5 and this implies that sleep problems are closely associated with the pathophysiology of BD.
The circadian rhythm regulates the daily rhythms of physiology and behavior, such as the sleep-wake cycle, core body temperature, hormonal secretion, and mood. 6 Recent studies have also suggested that circadian rhythm dysfunction significantly affects mood regulations in mood disorders, especially in BD. 4, [7] [8] [9] [10] [11] The genetic vulnerability of circadian rhythms may affect the sleep-wake cycle and hormonal secretion, including that of dopamine and serotonin, which consequently cause sleep problems and mood dysregulations of BD. 12 In addition, these abnormalities could influence each other in complex and bidirectional ways. 4 The aim of this review was to summarize and discuss the recent researches on the relations between circadian rhythm dysfunction and BD (listed in Table 1 ). Moreover, I discuss the clinical implication of circadian rhythm dysfunction on the clinical diagnosis and treatment of BD.
CIRCADIAN RHYTHM MARKERS IN BD Sleep and circadian rhythm
Sleep disturbances are common in BD patients in any state, including the euthymic state; however, the disturbance pattern varies with the mood state. During the manic state, the majority of patients (66-99%) experience a reduced need for sleep. [65] [66] [67] In addition, polysomnography has confirmed the common occurrence of shortened REM sleep latency in the manic state. 68, 69 During the depressive state, insomnia (40-85%) 70, 71 and hypersomnia (23-78%) [70] [71] [72] have been commonly reported in previous studies. However, there is no consensus available for bipolar depression through polysomnographic studies. 4 Sleep disturbances have also been reported to be frequent in the euthymic state. 5 Past studies have demonstrated that the sleep disturbances in the euthymic state included not only insomnia [73] [74] [75] but also sleep-wake rhythm disorders, 76 especially delayed sleep-wake phase disorders, 13, 14 suggesting that circadian rhythm dysfunction could be involved in the pathophysiology of BD. Pinho et al. 16 observed a relation among biological rhythm (as measured by the Biological Rhythms Interview of Assessment in Neuropsychiatry [BRIAN]), 15 depressive symptoms, and functional impairment in BD patients. 16 A dose-dependent relation was noted between the severity of depressive symptoms and the degree of biological rhythm disturbance. Furthermore, biological rhythm disturbance was found to be an independent predictor of psychosocial functional impairment.
Chronotype
Chronotype is the individual trait-like preference for daily activity and wakefulness (morningnesseveningness). 77 Circadian rhythm and chronotype preference are closely related. The eveningness chronotype could be independently associated with mood regulation, regardless of sleep quality, sleep duration, sleep timing, and sleep debt. 78 In addition, the eveningness chronotype has been reported to be associated with the delayed circadian phase in mood disorders. 79 Several studies have shown that euthymic BD patients are more likely to demonstrate the eveningness chronotype than healthy individuals, [18] [19] [20] [21] [22] except for one study that did not demonstrate any significant difference in chronotype between BD patients and controls, as measured by the Munich ChronoType Questionnaire. 80 The consensus on the relation between chronotype and depressive symptoms in BD remains inconsistent. For instance, Giglio et al. 22 reported no significant association between depressive symptoms and chronotype. On the other hand, Wood et al. 21 reported that the severity of depressive symptoms was associated with the eveningness chronotype. Seleem et al. 81 conducted a longitudinal study on BD patients (n = 257) as compared with non-BD psychiatric patients (n = 105) and healthy controls (n = 55) for an average of 27 months and found were associated with pathophysiology of BD. ・Irregularity of the social zeitgeber and stressful life events may affect mood episodes. [42] [43] [44] [45] Differences between MDD and BD ・Delayed sleep-wake phase and lower levels and later timing of melatonin secretion were frequently observed in BD, compared with MDD. 25, 27, 46 ・Circadian rhythm dysfunction may be a trait marker and a diagnostic predictor of BD in mood disorders. 17, 47 Circadian rhythm dysfunction in the clinical course ・Irregularity of the social zeitgeber was associated with onset and relapse of mood episodes in BD. 42, 48 ・Circadian rhythm dysfunction could predict relapse of mood episodes. [49] [50] [51] [52] Treatment focusing on circadian rhythm ・Mood-stabilizing mechanisms of lithium were associated with circadian rhythm. 40, [53] [54] [55] ・Adjunctive melatonin and its agonist may be effective for prevention of relapse of mood episode. 56, 57 ・Adjunctive light therapy may be effective for depressive symptoms. [58] [59] [60] ・Adjunctive dark therapy may be effective for manic symptoms.
61
・IPSRT could be effective for relapse prevention 62 as well as depressive symptoms.
63
・CBTI-BP may be effective for relapse prevention. 64 that the disturbances of sleep timing and eveningness chronotype were prominent in BD patients, regardless of their mood state, suggesting that the eveningness chronotype is a trait marker of BD.
Melatonin
Melatonin is a hormone secreted mainly from the pineal gland, showing circadian variation in its level, which is governed by the central circadian pacemaker in the suprachiasmatic nuclei of the hypothalamus. 82 Several studies have reported abnormalities in melatonin secretion in BD patients. [23] [24] [25] [26] [27] [28] The differences in the amount and timing of melatonin secretion may depend on the mood states. Advanced peak time and increased amount of melatonin secretion have been observed in the manic state. 23, 24 Conversely, delayed peak time and decreased amount of melatonin secretion have been found in the depressive and euthymic states. [25] [26] [27] Kennedy et al. 28 investigated the serum melatonin levels throughout the manic, depressive, and euthymic states in BD patients and found that the serum melatonin levels in all states were significantly lower in patients than in healthy controls, with no significant difference in the serum melatonin level among all states, suggesting that low melatonin secretion acts as a trait maker, rather than as a state maker, of BD, irrespective of the mood state.
Genetics
Several studies have suggested that clock genes are associated with the pathophysiology and clinical course of BD. The CLOCK gene has been widely reported as a key clock gene. [29] [30] [31] [32] [33] Benedetti et al. 30 suggested that single nucleotide polymorphism (SNP) in the 3 0 -flanking region of CLOCK (3111T/ C) is associated with the recurrence of mood episodes. Some studies have also suggested that the polymorphism of CLOCK 3111 T/C SNP is associated with delayed sleep-wake phase and eveningness chronotype. 32, 33 However, Kishi et al. 83 detected no significant association between CLOCK and BD, and they suggested that CLOCK does not play a major role in the pathophysiology of BD.
It has also been suggested that ARNTL,
34
NR1D1, 24 PER1, 24 PER3, 34 CRY2, 35, 36 and TIME-LESS 37 are associated with BD. Several studies have focused on the glycogen synthase kinase 3 beta (GSK3-β), which is involved in the phosphorylation of clock gene products. [38] [39] [40] 84 Of these, Benedetti et al. 38, 39 identified that GSK-3β was associated with the age of onset of BD. Conversely, another study reported that GSK-3β was not associated with the development of BD. 41 Genome-wide association studies have shown that several genes, each of the modest effect, were identified as being associated with susceptibility for BD. 85, 86 However, these genetic effects are probabilistic and nonspecific for the identification of endophenotype. 87 Circadian rhythm dysfunction may occur as a result of gene-environment interaction. A recent study demonstrated that BD patients with CLOCK polymorphism are likely to attempt suicide after exposure to early life stressful events, and this implies an interaction between the genetic vulnerability and environmental stress during the clinical course of BD. 29 
Social time cues and life events
Social time cues, such as bedtime, mealtime, beginning and ending of work, and exercises, 88 play an important role in the entrainment of the sleep-wake rhythm. The social zeitgeber theory 89 which is one of the prominent theories of the etiology of mood symptoms in BD, has proposed that the regularity of the social zeitgeber may promote internal synchronization of circadian rhythms, resulting in the stabilization of mood symptoms. Therefore, irregularity of the social zeitgeber could contribute to circadian rhythm dysfunction as well as to consequent relapse. Several studies have suggested that BD patients showed a greater irregularity of the social zeitgeber, as assessed by the Social Rhythm Metric, 90 when compared with healthy controls even in a euthymic state. 42 Stressful life events may also contribute to the clinical course of BD as they are related to the irregularity of the social zeitgeber. Longitudinal studies have demonstrated that BD patients are likely to have experienced stressful life events prior to the onset of depressive 43 and manic episodes. 44, 45 
RELATIONS BETWEEN CIRCADIAN RHYTHM, EXTERNAL TIME CUES, AND MOOD
The relation between circadian rhythm, external time cues, and mood dysfunction in BD could be complicated and bidirectional. Genetic vulnerabilities may affect the circadian rhythm dysfunction in BD. Early life stressful events are believed to be involved in the pathogenesis with gene-environment interaction. Consequently, these abnormalities possibly affect circadian rhythm dysfunction, irregularity of external time cues, and mood dysregulation, leading to the onset and relapse/recurrence of BD (Fig. 1) .
Focusing on the relation between the circadian rhythm phase and mood state during the clinical course of BD, a previous study indicated that changes in the sleep pattern occur prior to those in mood patterns in BD patients, indicating that sleep dysregulation may trigger manic/depressive symptoms and the onset of mood episodes. 49 A recent study revealed that biochemical circadian rhythm assessed by salivary cortisol, clock gene expression extracted from the buccal epithelial cells, and physical and sleep-wake activities assessed by actigraphy were associated with circadian phase advancement in acute manic episodes and circadian phase delay in acute mixed and depressive episodes, respectively. 91 Interestingly, these abnormalities of the circadian rhythm markers recovered similar to that in healthy controls after the treatment. Taken together, these results suggest close relations between the circadian phase shift and mood episodes during the clinical course of BD.
DIFFERENCES IN THE CIRCADIAN RHYTHM DYSFUNCTION BETWEEN MAJOR DEPRESSIVE DISORDER AND BD
Although circadian rhythm dysfunctions are commonly observed in major depressive disorder (MDD) patients as well as in BD patients, previous studies have demonstrated differences in circadian rhythm dysfunction between the two groups of patients. 17, 25, 27, 46, 47, 92 Robillard et al. 46 showed that young patients with BD are likely to demonstrate a delayed sleep-wake phase as compared with those with MDD and controls. Notably, two studies compared melatonin secretion in BD patients to that in MDD patients and reported similar results; that is, BD patients showed significantly lower levels and later timing of melatonin secretion than MDD patients, 25, 27 indicating that circadian rhythm dysfunction may be more prominent in BD.
It is difficult to distinguish the depressive episodes of BD from those of MDD under a clinical setting, particularly in the early stage of the disorders, mainly because depressive symptoms are common in both BD and MDD. Previous studies have identified predictors of BD in mood disorders, such as the early onset of mood episode, family history of BD, and larger number of previous mood episodes. 93 Circadian rhythm dysfunction is also believed to be a candidate predictor. 47 Duarte Faria et al. 17 found that biological rhythm dysfunction, measured by BRIAN, was greater in BD than in MDD patients. In addition, they also found that biological rhythm dysfunction was observed in euthymic patients, but not in MDD patients, suggesting that biological rhythm dysfunction is a trait marker that potentially differentiates from MDD. 17 A recent study found that the rate of comorbid circadian rhythm sleepwake disorders, based on the criteria of the International Classification of Sleep Disorders, 94 in remitted patients was significantly higher than in MDD patients, suggesting that comorbid circadian rhythm sleep-wake disorders as well as other predictors could be a diagnostic predictor for BD in remitted mood disorders. 47 
SIGNIFICANCE OF CIRCADIAN RHYTHM IN THE CLINICAL COURSE OF BD
A few studies have investigated the impact of sleep disturbances and circadian rhythm dysfunction on the clinical course of BD. Circadian rhythm dysfunctions can trigger the first onset of mood episode. A 3-year longitudinal study found that irregularity of the social zeitgeber can predict the first onset of mood episodes in patients at risk for BD. 48 In another study, Shen et al. 42 revealed that irregularity of the social zeitgeber could predict the onset of depressive and hypomanic/manic episodes in bipolar spectrum individuals. In addition, sleep and circadian dysfunction could also predict relapse. Bauer et al. 49 reported that changes in the sleep-wake cycle were likely to occur prior to mood changes during the clinical course of BD, which indicated that changes in the sleep-wake cycle may trigger relapse. A study with a 2-year longitudinal design found that abnormal sleep duration in recovered patients may act as a risk indicator for hastened depressive recurrences. 50 Another study reported that irregularity of a sleep-wake cycle in remitted patients could predict relapse. 51 Takaesu et al. 52 conducted a 48-week prospective study and reported that comorbid circadian rhythm sleep-wake disorders in remitted patients can predict relapse during a follow-up period. Notably, most of these longitudinal studies suggested that sleep disturbances and circadian rhythm dysfunction predict relapse and should therefore be focused on as a target for relapse prevention in BD patients.
TREATMENT OF BD WITH A FOCUS ON CIRCADIAN RHYTHM
It has been suggested that chronobiological treatment, including pharmacological treatment, light and dark therapy, and psychosocial therapy, is effective for both the improvement of mood symptoms and relapse prevention in BD through the adjustment of sleep and circadian rhythm dysfunction, which imply a robust relation between pathophysiology and circadian rhythm. 95 Lithium is recommended in the standard maintenance treatment for the prevention of relapse of mood episodes. 96 Although the mood-stabilizing mechanism remains unclear, there has been growing interest in the possible mechanism of using lithium through circadian rhythm regulation. 53 Lithium is known to lengthen the period of the circadian rhythm and correct the phase-advanced circadian rhythm, which could contribute to its moodstabilizing effect. 54 A previous study reported that patients who responded to lithium developed a faster circadian rhythm than non-responders. 55 Lithium was reported to inhibit GSK-3β both directly and indirectly, which implies the occurrence of a certain relation between the pharmacological effects of lithium and the genetic factors of circadian rhythm. 40 Conversely, another study reported that the inhibitors of GSK-3β shortened the circadian period of mammalian cells instead of lengthening it. 97 Considering these, although both lithium and GSK-3β are involved in the cellular clock mechanism, the relation between lithium and GSK-3β in the mood-stabilizing mechanism is still unclear. A systematic review suggested that chronic lithium treatment stabilized the free-running activity rhythm and that the lithium response was associated with the expression of clock genes, such as NR1D1, CRY1, ARNTL, and PER2.
53
Melatonin regulates circadian rhythm and is a candidate for the modification of circadian rhythm misalignment and sleep-wake cycle of BD. Melatonin was reported to be effective not only for sleep disturbances but also for mood symptoms in BD. 56 Melatonin has a relatively small effect on sleep and may affect the mood symptoms that are mediated by circadian rhythm regulation. Norris et al. 57 conducted a randomized-controlled trial to test the effect of adjunctive ramelteon, an agonist of the melatonin receptors MT1 and MT2, in a euthymic state and found that ramelteon was effective for relapse prevention during a 24-week study period. Agomelatine, a potential agonist of the melatonin receptors MT1 and MT2 and an antagonist of 5HT 2C , induced a circadian phase-advancing effect. 98 Open-label studies have also suggested the effectiveness of agomelatine for mood symptoms. 99, 100 However, a recent randomized study concluded that an agomelatine adjunctive therapy was not superior to an adjunctive placebo therapy for treating acute bipolar depression. 101 Adjunctive light therapy may contribute to the improvement of depressive symptoms and to the reduction of residual symptoms for seasonal affective disorders like MDD and BD. 58 Benedetti et al.
59
revealed that combining light therapy with total sleep deprivation and lithium application could be effective not only for improving suicidality but also for prompting antidepressant response in drugresistant bipolar depression. A recent randomized double-blind placebo-controlled trial for investigating the efficacy of light therapy revealed that bright light therapy was effective in improving the depressive symptoms and did not increase the risk of manic switch in depressive BD patients. 60 Dark therapy aims to synchronize the circadian rhythm by placing manic episode patients in a dark room during the nighttime. Dark therapy has shown remarkable effects in manic patients in two case reports and in a pilot study. [102] [103] [104] Notably, a recent randomized placebo-controlled study showed that modified dark therapy, an additive treatment of blue-blocking glasses, was effective and feasible for application in manic patients. 61 As mentioned above, regularity of the social zeitgeber is believed to entrain sleep-wake rhythms. Stabilization of the social zeitgeber could improve mood symptoms and prevent relapse. The efficacy of interpersonal and social rhythm therapy (IPSRT) 62 -a psychosocial therapy targeted at stabilizing the daily rhythms combined with interpersonal psychotherapy -for BD has been reported in previous studies. 62, 63, 105 IPSRT has been reported to be effective for relapse prevention 62 as well as for the improvement of depressive episodes 63 Recently, there has been a growing interest in the efficacy of cognitive behavioral therapy for insomnia (CBT-I), 106 which includes sleep restriction therapy, stimulus control therapy, relaxing training, cognitive therapy, and sleep hygiene education, in the euthymic states. 95 Harvey et al. 64 developed a BD-specific modification of CBT-I (CBTI-BP), which focuses on sleep and circadian rhythm dysfunction by integrating elements from IPSRT, chronotherapy, and motivational interviewing, and investigated the effectiveness of CBTI-BP in the euthymic states. Their results suggest that CBTI-BP is associated with reduced risk of relapse and improved sleep and functioning on certain outcomes.
CONCLUSION
In conclusion, sleep disturbances and circadian rhythm dysfunction have been found to be common in BD. However, the relations between circadian rhythm dysfunction and the pathophysiology, onset, and clinical course of BD remain unclear. Findings about whether circadian rhythm dysfunction is a trait marker or a mood state dependent have been inconsistent. Some studies have suggested a relative circadian phase delay in depressive episodes and a phase advance in manic episodes. On the other hand, other studies have indicated that the relative circadian phase delay may be a trait marker of the disorder, independent of the mood state. In the future, further studies are warranted to clarify the relation between circadian rhythm dysfunction and the pathophysiology of BD. An appropriate treatment strategy combining pharmacological, psychosocial, and chronobiological treatments should be developed for the achievement of recovery from BD. Clinicians should focus more on the circadian rhythm dysfunction for the diagnosis and treatment of BD under a clinical setting.
